Breaking News

One 2 One Appoints General Manager

July 17, 2013

Blair brings more than 30 years of experience

Karen Blair has joined Hospira Inc. as general manager to lead One 2 One™, Hospira’s contract development and manufacturing services business. Mrs. Blair will be responsible for overall P&L accountability, sales, marketing, business development, and customer relationship management. She will also lead the One 2 One™ team, which includes operations, R&D, program management and other functions, to ensure the overall success of One 2 One™ business.
Mrs. Blair brings more than 30 years of experience across a broad spectrum of pharmaceutical marketing and general management roles as well as in contract manufacturing. She spent most of her career with Baxter Healthcare in roles of increasing responsibility in marketing, sales and general management, including holding the position of vice president / general manager of Baxter BioPharma Solutions . During her time at Baxter, she drove substantial growth of the contract manufacturing services business and promoted a culture of customer service excellence.
Karen Blair said, “I am very excited about the opportunity to contribute to the success of Hospira One 2 One™. For quite some time I had been observing One 2 One™ as one of the major competitors and now I will be helping to shape its future. The strength of this business, expertise in parenteral product manufacturing, is truly substantial. One 2 One™ has more than 20 years of experience in addressing customer challenges and developing best practices in small molecule and biologics fill/finish technology, lyophilization, and global commercialization. I envision a great future for One 2 One™ as a preferred partner for parenteral drug manufacturing.”
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.